# Genetic Counseling for Diverse Populations

## Introduction

Genomic medicine was built predominantly on data from populations of European descent, creating systemic disparities in the accuracy, utility, and accessibility of genetic services for diverse populations. Culturally responsive genetic counseling requires understanding how ancestry affects variant interpretation, recognizing barriers to access, and adapting communication to diverse belief systems and health literacy levels.

## The Diversity Gap in Genomics

### Reference Population Bias

As of recent analyses, approximately 86% of GWAS participants have been of European ancestry. Clinical variant databases (ClinVar, HGMD) are enriched for variants identified in European populations. gnomAD includes diverse populations but representation remains uneven, with African/African American, Latino/Admixed American, East Asian, and South Asian populations underrepresented relative to global demographics. The reference genome (GRCh38) was derived predominantly from a single individual of African-European ancestry.

### Consequences of the Diversity Gap

Higher VUS rates occur in underrepresented populations because variants common in non-European populations may lack functional or clinical data for classification. Misclassification risk is real: benign population-specific variants may be incorrectly classified as pathogenic due to absence from European-biased databases. For example, hypertrophic cardiomyopathy variants in African American patients have been misclassified as pathogenic, leading to inappropriate clinical management. Additionally, clinically important variants specific to underrepresented populations may be absent from testing panels.

![Bar chart showing the distribution of GWAS participants by ancestry compared to global population proportions, highlighting the diversity gap](images/genomics-diversity-gap.png)

## Cultural Competence in Genetic Counseling

### Core Principles

Cultural humility involves ongoing self-reflection and recognition of one's own biases and limitations in understanding other cultures. Intersectionality recognizes that patients exist at the intersection of multiple identities including race, ethnicity, religion, socioeconomic status, gender, and disability. Structural competence understands how social structures and systems create health disparities beyond individual cultural practices. Patient-centered communication adapts the counseling approach based on the individual patient's needs rather than assumptions based on group membership.

### Culturally Specific Considerations

Consanguinity is common in some Middle Eastern, South Asian, and North African communities and affects recessive disease risk, requiring sensitive, non-judgmental discussion; consanguinity-aware carrier screening panels are important in these populations. Some religious or spiritual frameworks attribute disease to divine will rather than genetic causation, and counselors must work within the patient's meaning-making framework. In collectivist cultures, health decisions may be made by the family rather than the individual, and the informed consent process should accommodate family members when the patient desires. Cultural and religious beliefs about contraception, pregnancy termination, and reproductive technologies vary widely and must be respected. Naming conventions and family structures including extended family, polygamous unions, informal adoption, and kinship care arrangements affect pedigree construction.

## Language and Health Literacy

### Language Access

Professional medical interpreters are required for patients with limited English proficiency; family members should not serve as interpreters for genetic counseling. Telephone and video interpretation services are available for less common languages. Written materials should be provided in the patient's preferred language at an appropriate reading level. Genetic terminology may not translate directly, and interpreters need pre-session briefing on key concepts.

### Health Literacy Strategies

The average adult reading level in the US is 6th-8th grade, while most genetic education materials are written above this level. Plain language should be used: "a change in a gene" rather than "pathogenic variant." Visual aids including diagrams, pictographs, and videos improve comprehension across literacy levels. Teach-back is essential for confirming understanding. Numeric literacy challenges are common, so natural frequencies (such as "3 out of 100") should be used rather than percentages alone.

![Examples of culturally adapted genetic counseling materials including multilingual pedigree forms, visual risk communication tools, and plain language result summaries](images/diverse-counseling-materials.png)

## Population-Specific Genetic Considerations

### African and African American Populations

Higher prevalence of sickle cell disease and trait, hemoglobin SC disease, and beta-thalassemia trait characterize this population. G6PD deficiency is important for pharmacogenomics (rasburicase, dapsone). CYP2D6*17 and *29 are reduced-function alleles more common in African populations that may be missing from some PGx panels. Higher VUS rates occur in hereditary cancer panel testing, requiring careful counseling. APOL1 risk variants associated with kidney disease risk have a carrier frequency of approximately 13% in African Americans.

### Ashkenazi Jewish Population

Elevated carrier frequencies exist for Tay-Sachs disease, Canavan disease, Gaucher disease, familial dysautonomia, cystic fibrosis, and others. Three specific BRCA1/2 founder mutations (BRCA1 185delAG, 5382insC; BRCA2 6174delT) account for most hereditary breast/ovarian cancer in this population, with a carrier frequency of approximately 1 in 40. Expanded carrier screening panels have been designed specifically for this population.

### South Asian Populations

Higher prevalence of beta-thalassemia carrier status is characteristic. Consanguinity-related increases in autosomal recessive conditions are seen. CYP2C19*2 has higher allele frequency, affecting clopidogrel response.

### East Asian Populations

HLA-B*15:02 has high prevalence, affecting carbamazepine safety. NUDT15*3 is important for thiopurine dosing. ALDH2*2 causes alcohol flush reaction with implications for alcohol-related cancer risk.

### Hispanic/Latino Populations

Admixed ancestry complicates population-based risk assessment. Higher prevalence of certain conditions such as 21-hydroxylase deficiency is seen. Underrepresentation in research databases leads to higher VUS rates.

## Addressing Mistrust and Historical Harm

Historical abuses including the Tuskegee Syphilis Study, Henrietta Lacks/HeLa cells, forced sterilization programs, and exploitation of Indigenous populations' samples create legitimate mistrust. These harms should be acknowledged honestly and transparently. Informed consent must be emphasized as a process, not just a document. Data sovereignty concerns, particularly for Indigenous communities, require attention. Partnering with community leaders and organizations builds trust. Research participation must benefit the communities contributing samples.

## Strategies for Reducing Disparities

Diversifying genomic databases through initiatives like H3Africa, All of Us, and GenomeAsia100K is essential. Workforce diversity through training and recruiting genetic counselors and geneticists from underrepresented backgrounds improves cultural responsiveness. Community engagement through partnerships with community organizations for outreach and education builds trust. Telegenetics expands access to rural and underserved areas. Advocacy supports policies that reduce financial barriers to genetic testing and counseling.

![Framework diagram showing strategies for achieving equity in genomic medicine spanning database diversification, workforce development, community engagement, and policy advocacy](images/genomic-equity-framework.png)

## Clinical Pearls

Higher VUS rates in non-European populations are a direct consequence of the diversity gap in genomic databases; this must be communicated to patients and clinicians to prevent misinterpretation. Professional medical interpreters, not family members, should be used for genetic counseling to ensure accuracy and protect the patient's right to unbiased information. Population-specific allele frequencies affect both disease risk assessment and pharmacogenomic recommendations; testing panels must be evaluated for ancestral coverage. Cultural humility is an ongoing practice, not a checklist; each patient encounter requires individual assessment of communication needs, decision-making preferences, and value systems.

## References

1. Popejoy AB, Fullerton SM. Genomics is failing on diversity. *Nature*. 2016;538(7624):161-164.
2. Manrai AK, Funke BH, Rehm HL, et al. Genetic misdiagnoses and the potential for health disparities. *New England Journal of Medicine*. 2016;375(7):655-665.
3. Lewis ACF, Molina SJ, Appelbaum PS, et al. Getting genetic ancestry right for science and society. *Science*. 2022;376(6590):250-252.
4. Mittman IS, Downs K. #GeneChat: The intersection of genetic counseling and cultural competence. *Journal of Genetic Counseling*. 2012;21(3):427-437.